{"schema":"hottub-news/prospects/v1","item":{"id":"n_d4mumogt766tzdiiljcq","title":"FDA requires GLP-1 drugs to carry warning labels about rare risk of vision loss","title_en":null,"url":"https://www.phillyvoice.com/glp1-weight-loss-drugs-vision-loss-fda-warnings","outlet":"phillyvoice.com","published":"2026-11-11T00:45:00Z","sponsored":false,"page":"https://hottub.news/articles/n_d4mumogt766tzdiiljcq"},"prospects":[{"name":"Courtenay Harris Bond","kind":"person","role":"reporter","company":"phillyvoice.com","website":"https://phillyvoice.com/","source":"https://www.phillyvoice.com/glp1-weight-loss-drugs-vision-loss-fda-warnings","note":"Wrote: FDA requires GLP-1 drugs to carry warning labels about rare risk of vision loss","reason":"Reporter at phillyvoice.com; wrote “FDA requires GLP-1 drugs to carry warning labels about rare risk of vision loss” on 2026-11-11","group":"Reporters","add_url":"https://crm.joinhottub.com/relationships/add#name=Courtenay%20Harris%20Bond&company=phillyvoice.com&website=https%3A%2F%2Fphillyvoice.com%2F&source=https%3A%2F%2Fwww.phillyvoice.com%2Fglp1-weight-loss-drugs-vision-loss-fda-warnings&note=Wrote%3A%20FDA%20requires%20GLP-1%20drugs%20to%20carry%20warning%20labels%20about%20rare%20risk%20of%20vision%20loss","propose":{"name":"Courtenay Harris Bond","kind":"person","reason":"Reporter at phillyvoice.com; wrote “FDA requires GLP-1 drugs to carry warning labels about rare risk of vision loss” on 2026-11-11","requestId":"news:n_d4mumogt766tzdiiljcq:Reporter:50ba62f1:0c745fa4","company":"phillyvoice.com","website":"https://phillyvoice.com/","sourceUrl":"https://www.phillyvoice.com/glp1-weight-loss-drugs-vision-loss-fda-warnings"}},{"name":"phillyvoice.com","kind":"organization","role":"outlet","website":"https://phillyvoice.com/","source":"https://www.phillyvoice.com/glp1-weight-loss-drugs-vision-loss-fda-warnings","note":"Published: FDA requires GLP-1 drugs to carry warning labels about rare risk of vision loss (2026-11-11)","reason":"Published “FDA requires GLP-1 drugs to carry warning labels about rare risk of vision loss” on 2026-11-11","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=phillyvoice.com&kind=organization&website=https%3A%2F%2Fphillyvoice.com%2F&source=https%3A%2F%2Fwww.phillyvoice.com%2Fglp1-weight-loss-drugs-vision-loss-fda-warnings&note=Published%3A%20FDA%20requires%20GLP-1%20drugs%20to%20carry%20warning%20labels%20about%20rare%20risk%20of%20vision%20loss%20%282026-11-11%29","propose":{"name":"phillyvoice.com","kind":"organization","reason":"Published “FDA requires GLP-1 drugs to carry warning labels about rare risk of vision loss” on 2026-11-11","requestId":"news:n_d4mumogt766tzdiiljcq:Outlet:50f2ebac:5138467b","website":"https://phillyvoice.com/","sourceUrl":"https://www.phillyvoice.com/glp1-weight-loss-drugs-vision-loss-fda-warnings"}}],"someone_else":{"source":"https://www.phillyvoice.com/glp1-weight-loss-drugs-vision-loss-fda-warnings","note":"In the news: FDA requires GLP-1 drugs to carry warning labels about rare risk of vision loss (phillyvoice.com, 2026-11-11)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}